http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021075451-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_afccd56726bb8fd92de04cd8e33714fa |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 |
filingDate | 2020-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38189176c2c4957dad891b1c0d108292 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_503a0121d3407bf2ad0b24b9c91eb41f |
publicationDate | 2021-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2021075451-A1 |
titleOfInvention | Blood-tissue barrier in vitro model and method for evaluating blood-tissue barrier transportability of drug |
abstract | This blood-tissue barrier in vitro model contains: a collagen vitrigel membrane; human vascular endothelial cells disposed on the top surface of this collagen vitrigel membrane; organ-derived cells disposed on the bottom surface of this collagen vitrigel membrane; and a culture solution. The human vascular endothelial cells are dependent on the organ-derived cells and are capable of differentiating into the vascular endothelial cells of that organ. |
priorityDate | 2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 46.